If you have PMOS (PCOS) and you are thinking about trying to conceive one day, someone has probably mentioned egg quality to you already, usually followed by a vague warning and not much else. Maybe a doctor said it in passing before moving on to talk about the pill. Maybe you have been quietly Googling at midnight, trying to work out what it actually means for your chances.

A quick note on names: PCOS has been renamed PMOS (polyendocrine metabolic ovarian syndrome), and the NHS now uses the new name. We use both here while the change settles in. Here is what the rename means for you.

Short answer: PCOS can affect egg quality through insulin resistance, elevated androgens, and increased oxidative stress, all of which interfere with how follicles develop. But egg quality is not a fixed trait. It is shaped by the metabolic environment your eggs develop in over roughly the final three months before ovulation, and several nutrients and lifestyle factors have real, if sometimes modest, research behind them. This article walks through what the evidence actually shows, including where it is stronger and where it is thinner than wellness content usually admits.

What Does PMOS (PCOS) Actually Do to Egg Quality?

Short answer: PCOS disrupts egg development mainly through insulin resistance, elevated androgens, and increased oxidative stress, three interconnected factors that interfere with follicle maturation and the energy supply eggs need to develop properly.

Egg quality is not a single fixed trait. It is the result of a process. Eggs spend months developing before they are released, and what happens during that window, hormonal signalling, oxidative stress levels, and cellular energy production, shapes how viable those eggs end up being.

In women with PCOS, research points to a few things tending to go wrong in that process. Insulin resistance is common in PCOS, and it drives up insulin levels, which in turn raises androgen production in the ovaries. High androgens disrupt the normal growth and maturation of follicles, meaning eggs may not develop properly or ovulation may not happen consistently. Research also shows that oxidative stress, an imbalance between free radicals and the antioxidants that neutralise them, tends to run higher in women with PCOS, and eggs are particularly vulnerable to this kind of damage. Studies looking specifically at PCOS ovarian tissue have also found signs of impaired mitochondrial function in granulosa cells, the cells that support a developing egg, including lower energy output. Since eggs require enormous amounts of cellular energy to mature and fertilise, this matters.

You are not imagining it. The biology is real. But it is also responsive, which is the part that gets left out of most conversations about PCOS and fertility.

Can You Actually Improve Egg Quality With PCOS?

Short answer: Yes, to a meaningful degree. While genetics set a baseline, the final stretch of egg development is shaped by your metabolic environment, and that environment responds to nutrition, blood sugar stability, sleep, and targeted supplementation.

The final, most nutrient-sensitive growth phase before ovulation is often described as lasting around three months, which is why the "ninety day rule" gets mentioned so often in fertility content. It is worth being precise about what that actually refers to. The full journey from a dormant primordial follicle to ovulation can take the better part of a year. What the ninety day figure really points to is the last, gonadotropin-responsive stretch of that journey, the window most sensitive to the hormonal and metabolic environment around it, and the one worth focusing your efforts on.

This is both the sobering and the hopeful part. You have more influence over egg quality than most people realise, particularly once you understand the specific mechanisms driving your PCOS. Your diagnosis is a starting point, not a verdict.

Does Myo-Inositol Actually Improve Egg Quality in PCOS?

Short answer: Research suggests myo-inositol supplementation, typically at 2000 to 4000mg daily, may improve embryo quality and clinical pregnancy rates in women with PCOS undergoing fertility treatment, though myo-inositol has no authorised EU or GB health claim, so this should always be framed as research-attributed rather than a direct promise.

Myo-inositol is a naturally occurring compound involved in insulin signalling, and women with PCOS often have altered levels of it. A 2025 systematic review and meta-analysis pooling 17 randomised trials found that myo-inositol supplementation was associated with improved clinical pregnancy rates and a higher proportion of higher-grade embryos in women with PCOS undergoing assisted reproduction, at doses that were commonly in the 2000 to 4000mg daily range, matching what is used in the Preconception formula. An earlier, independently conducted randomised trial found that myo-inositol combined with a small amount of d-chiro-inositol improved IVF outcomes compared with d-chiro-inositol given alone.

One honest nuance worth including: in the pooled trial data, markers like antral follicle count and AMH sometimes moved downward in the treatment groups. Researchers interpreted this as reflecting more efficient, better-regulated ovarian activity rather than a sign of depleted reserve, but it is a detail that deserves mentioning rather than glossing over, since a falling number can understandably worry someone reading quickly.

It is also worth flagging directly that inositol research as a field has had real credibility problems in recent years, with a number of older, frequently cited trials in this exact space formally retracted or placed under review for data integrity concerns. That is precisely why the citation above points to a recent, independently authored systematic review rather than repeating an older single study by name.

Does CoQ10 Actually Support Egg Quality in PCOS?

Short answer: The strongest evidence for CoQ10 and egg quality comes from women with diminished ovarian reserve or age-related fertility decline, not PCOS specifically. In PCOS, controlled research has shown CoQ10 improving insulin and androgen markers rather than directly measuring oocyte quality.

CoQ10, particularly in its active ubiquinol form, is essential for mitochondrial energy production, and because egg maturation requires substantial cellular energy, supporting mitochondrial function is a reasonable mechanism to explore. The research that most directly shows CoQ10 improving embryo quality and ovarian response comes from studies of women with diminished ovarian reserve undergoing IVF, a different population from PCOS.

The clearest PCOS-specific randomised trial measured hormonal and metabolic outcomes rather than oocyte quality directly. It found that 200mg of CoQ10 daily over eight weeks improved insulin sensitivity and reduced free testosterone in women with PCOS. That is a genuinely useful finding, since both insulin resistance and elevated androgens are part of the mechanism disrupting egg development described earlier in this article. But it is a more honest way to describe CoQ10's role in PCOS specifically than borrowing the stronger, more direct oocyte-quality language used in diminished ovarian reserve research. CoQ10 has no authorised EU or GB health claim, so any mention of its role stays research-attributed rather than presented as fact.

What About Folate and the MTHFR Myth?

Short answer: Folate, particularly as 5-methyltetrahydrofolate, supports the recommended intake for anyone trying to conceive, and it is genuinely easier for the body to use directly. But the popular claim that people with an MTHFR gene variant "cannot convert" folic acid at all is an overstatement not supported by major genetics guidance.

Folic acid is the synthetic form of vitamin B9 commonly found in supplements, and it requires an enzymatic conversion step in the body before it can be used. Folate as 5-methyltetrahydrofolate, or 5-MTHF, is the already-active form, which is why it is included in the Preconception formula at the Department of Health recommended dose of 400mcg. Folate contributes to maternal tissue growth during pregnancy, an authorised claim.

Here is the nuance most wellness content skips. People with an MTHFR gene variant do process folic acid somewhat less efficiently, and this can lower blood folate levels in a dose-dependent way depending on which variant they carry. But major genetics guidance, including from the US Centers for Disease Control and Prevention, is explicit that people with MTHFR variants can still process folic acid, and that routine MTHFR testing has minimal clinical value for most people. If you have been told you "cannot use" folic acid because of MTHFR, that is stronger than the evidence actually supports. Choosing 5-MTHF is a reasonable, precautionary preference many women make, not a physiological necessity for everyone with the variant.

Does NAC Support Ovulation and Egg Quality in PCOS?

Short answer: A pooled analysis of multiple randomised trials found that N-acetyl cysteine supplementation improved insulin and glucose markers and supported ovulation-related outcomes in women with PCOS, though NAC has no authorised EU or GB health claim.

NAC is a precursor to glutathione, one of the body's most important antioxidants, which is relevant given the oxidative stress patterns discussed earlier. A 2023 systematic review and meta-analysis pooling eleven randomised controlled trials and more than 800 women with PCOS found that NAC supplementation reduced fasting glucose and insulin and improved lipid markers compared with placebo, describing it as a promising nutritional option. It is worth being direct here too: the individual trial literature testing NAC alongside fertility medications for PCOS has been affected by a wave of data-integrity retractions in recent years, so this section deliberately relies on the pooled meta-analysis findings rather than any single older trial.

What About Alpha-Lipoic Acid?

Short answer: Research suggests alpha-lipoic acid may improve insulin resistance and some metabolic markers in PCOS, but the evidence base is still small, so this should be read as promising rather than settled.

Alpha-lipoic acid is an antioxidant with a dual role in PCOS research, supporting both insulin sensitivity and antioxidant defence, both of which connect back to the mechanisms behind egg quality. A 2024 systematic review and meta-analysis found improvements in fasting glucose and insulin resistance with alpha-lipoic acid supplementation, though it was built from only seven randomised trials, and not every metabolic or hormonal outcome reached statistical significance across them. It has no authorised EU or GB health claim, so it is included in the Preconception formula as a research-attributed ingredient rather than a guaranteed-effect one.

Does Zinc Actually Improve Egg Quality?

Short answer: Zinc deficiency is associated with lower oocyte and embryo quality in the research available, and zinc has an authorised claim for normal fertility and reproduction, but there is not yet strong human trial evidence that zinc supplementation specifically improves egg quality in PCOS.

Zinc is essential for DNA synthesis and ovarian function, and a systematic review found that women with PCOS tend to have lower serum zinc levels than women without the condition. Separately, a small study measuring zinc levels directly in follicular fluid found that lower zinc was associated with fewer mature eggs and lower embryo quality. This is a real and biologically sensible pattern, but it is mostly built on association studies rather than trials testing whether supplementing zinc actually changes egg quality outcomes, so it is fair to say the link is established more clearly than the supplementation benefit is. Zinc contributes to normal fertility and reproduction and to normal DNA synthesis, both genuinely authorised claims.

What About D-Chiro-Inositol? Why Isn't It the Main Ingredient?

Short answer: D-chiro-inositol works alongside myo-inositol in the body in a specific ratio, and research looking at follicular fluid has found that unusually high D-chiro-inositol levels relative to myo-inositol may be associated with lower blastocyst quality, which is part of why the Preconception formula centres on myo-inositol rather than combining large amounts of both.

This comes up a lot in PCOS communities online, so it is worth addressing directly. Myo-inositol and d-chiro-inositol are related compounds that the body converts between and uses in a fairly specific physiological ratio. One study measuring D-chiro-inositol levels directly in the follicular fluid surrounding developing eggs found that higher concentrations were associated with lower blastocyst quality, consistent with the theory that disrupting the natural ratio between the two forms may not be helpful for egg development. This is a single study rather than a large, settled body of evidence, so it is a reasonable caution rather than a proven mechanism. Some of the older literature comparing the two forms head to head has since been affected by data-integrity concerns too, which is another reason this article leans on the follicular fluid finding rather than an older comparative claim. Myo-inositol, which has a larger and more consistent evidence base, remains the focus of the Preconception formula.

Does Lifestyle Actually Move the Needle on Egg Quality?

Short answer: Yes, particularly blood sugar stability, protein intake, sleep, and the type of exercise you choose, since all four interact with the same insulin and androgen pathways driving egg quality issues in PCOS.

Because insulin resistance sits at the centre of PCOS, stabilising blood sugar has a direct downstream effect on hormone levels and ovarian function. This does not require an extreme approach. Protein with every meal, reducing refined carbohydrates, and prioritising fibre are simple, sustainable changes with a real mechanistic basis.

Protein specifically has research behind it beyond the general blood sugar argument. A widely cited analysis from the Nurses' Health Study II followed over 18,000 women over eight years and found that replacing a small proportion of daily energy from animal protein with plant protein was associated with a meaningfully lower risk of ovulatory infertility. It is one of the more concrete, well-powered findings in this whole area, and it points toward a genuinely actionable shift rather than a vague "eat healthier" suggestion.

Exercise matters too, but the type matters more than people expect. High-intensity exercise can be counterproductive when cortisol is already elevated, which is common in PCOS. Strength training and walking tend to improve insulin sensitivity without adding to that stress load, while frequent high-intensity sessions on an already depleted system can work against you.

Sleep is the piece most often skipped. Insulin sensitivity reliably worsens with poor sleep, so neglecting it while optimising everything else works against you. Seven to nine hours is not a luxury here, it functions closer to a metabolic requirement.

How Long Does It Actually Take to See a Difference?

Short answer: Most guidance points to at least ninety days of consistent nutritional support, because that roughly matches the final, most hormone-sensitive growth window of the eggs due to be released in the coming cycles, not because supplements simply take time to work in a vague sense.

Eggs that will ovulate three months from now are already partway through that final growth window today. If you are planning ahead before trying to conceive, that three-month runway is worth using deliberately rather than starting changes the week you decide to try.

What Mistakes Do People Make When Trying to Improve Egg Quality?

Treating egg quality as fixed. Genetics set a baseline, but the final growth phase of an egg is genuinely responsive to your metabolic environment, so writing off egg quality as unchangeable skips real, evidence-backed opportunities.

Starting supplements the week before trying to conceive. Given the roughly ninety day development window, starting well in advance matters more than most people realise.

Stacking every supplement mentioned online at once. More is not automatically better, and combining high doses of both inositol forms specifically may work against the natural ratio your body relies on.

Ignoring sleep and exercise intensity while focusing only on supplements. Nutrients support the same pathways that sleep and appropriate exercise support. Skipping one while optimising the other leaves real benefit on the table.

Frequently Asked Questions About PCOS and Egg Quality

Can PCOS really affect egg quality?

Yes. Research links PCOS to lower egg quality through insulin resistance, elevated androgens, and oxidative stress, all of which interfere with how follicles develop. These are modifiable factors rather than a fixed outcome.

Does myo-inositol actually improve egg quality in PCOS?

A 2025 systematic review of 17 randomised trials found myo-inositol supplementation, typically at 2000 to 4000mg daily, was associated with improved embryo quality and clinical pregnancy rates in women with PCOS undergoing fertility treatment. It has no authorised EU or GB health claim, so this is research-attributed rather than a guaranteed outcome.

How long before trying to conceive should I start supporting egg quality?

At least ninety days is the commonly recommended window, since that roughly matches the final, most nutrient-sensitive stretch of a developing egg's growth before ovulation.

Is folate different from folic acid, and does MTHFR mean I cannot use folic acid?

Folate as 5-methyltetrahydrofolate is the active form the body can use directly, while folic acid needs converting first. People with an MTHFR variant process folic acid somewhat less efficiently, but major genetics guidance is clear that they can still use it, so claims that MTHFR carriers cannot use folic acid at all are overstated.

Can I take the Preconception supplement alongside other medication?

Always speak to your GP before starting any supplement alongside existing medication, particularly if you are pregnant, breastfeeding, or have a diagnosed condition.

Final Thoughts

PCOS makes egg quality more complicated. It does not make it fixed. The evidence for supporting it, myo-inositol, folate as 5-MTHF, CoQ10, NAC, alpha lipoic acid, zinc, and the basics of blood sugar, protein, sleep and exercise, is real, though it varies in strength from one nutrient to the next, and an honest article says so rather than flattening every ingredient into the same confident promise.

It is not a magic fix. But it gives your body what it is often missing, in doses that broadly match what the research has actually used. Your body is trying to tell you something.

Related Reading

• PCOS and Insulin Resistance: Understanding the Root Cause
• Inositol for PCOS: What the Research Actually Shows
• Understanding PCOS and Pregnancy: Risks, Symptoms, and Treatments

Health Disclaimer: This article is for educational purposes only and does not replace personalised medical advice. Always consult a qualified healthcare professional before starting any supplement, particularly if you have a diagnosed condition, are pregnant, breastfeeding, or taking other medication.

References

1. Rambaran, N., & Islam, M. S. (2025). Decoding androgen excess in polycystic ovary syndrome: Roles of insulin resistance and other key intraovarian and systemic factors. World Journal of Diabetes, 16(7), 108789.
2. Yan, H., et al. (2024). Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies. Reproductive Biology and Endocrinology, 22, 1-16.
3. Xie, C., Lu, H., Zhang, X., An, Z., Chen, T., Yu, W., Wang, S., Shang, D., & Wang, X. (2023). Mitochondrial abnormality in ovarian granulosa cells of patients with polycystic ovary syndrome. Molecular Medicine Reports, 29(2), 27.
4. Akbari Sene, A., Saeedzarandi, M., Yazdizadeh, M., Ghaffari, S. R., Amjadi, F., Zandieh, Z., & Moradi, Y. (2025). The effect of myo-inositol on assisted reproductive technology outcomes in women with polycystic ovarian syndrome: A systematic review and meta-analysis of randomized clinical trial studies. International Journal of Reproductive Biomedicine, 23(5), 353-376.
5. Colazingari, S., Treglia, M., Najjar, R., & Bevilacqua, A. (2013). The combined therapy myo-inositol plus d-chiro-inositol, rather than d-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Archives of Gynecology and Obstetrics, 288(6), 1405-1411.
6. Ravanos, K., Monastra, G., Pavlidou, T., Goudakou, M., & Prapas, N. (2017). Can high levels of D-chiro-inositol in follicular fluid exert detrimental effects on blastocyst quality? European Review for Medical and Pharmacological Sciences, 21(23), 5491-5498.
7. Izadi, A., Ebrahimi, S., Shirazi, S., Taghizadeh, S., Parizad, M., Farzadi, L., & Pourghassem Gargari, B. (2019). Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism, 104(2), 319-327.
8. Hickey, S. E., Curry, C. J., & Toriello, H. V. (2013). ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genetics in Medicine, 15(2), 153-156.
9. Liu, J., Su, H., Jin, X., Wang, L., & Huang, J. (2023). The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis. Frontiers in Nutrition, 10, 1209614.
10. Abu-Zaid, A., Baradwan, S., Bukhari, I. A., et al. (2024). The effect of alpha-lipoic acid supplementation on anthropometric, glycemic, lipid, oxidative stress, and hormonal parameters in individuals with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials. Obstetrics & Gynecology Science, 67(1), 17-29.
11. Abedini, M., Ghaedi, E., Hadi, A., Mohammadi, H., & Amani, R. (2019). Zinc status and polycystic ovarian syndrome: A systematic review and meta-analysis. Journal of Trace Elements in Medicine and Biology, 52, 216-221.
12. Chavarro, J. E., Rich-Edwards, J. W., Rosner, B. A., & Willett, W. C. (2008). Protein intake and ovulatory infertility. American Journal of Obstetrics & Gynecology, 198(2), 210.e1-210.e7.

References